教育干预措施以加强对在炎症性肠病患者中平衡工作和治疗的支持
Nobuhiro Ueno1,2, Aki Sakatani3, Katsuyoshi Ando4
1Department of General Medicine, Asahikawa Medical University Hospital, Midorigaoka-Higashi 2 - 1- 1- 1, Asahikawa, Hokkaido, 078 - 8510, Japan. u-eno@asahikawa-med.ac.jp.
Journal of gastroenterology
|April 12, 2025
概括
一个教育计划显著提高了医疗保健专业人员对支持炎性肠病 (IBD) 患者的工作与生活平衡的认识和兴趣. 基于讲座的学习被证明是最有效的,特别是对医疗人员来说,强调了需要量身定制的培训.
科学领域:
- 胃肠病学和肝病学
- 职业健康 职业健康 职业健康
- 医学教育 医学教育
背景情况:
- 炎症性肠病 (IBD) 对就业和工作生产力构成挑战.
- 支持平衡工作和治疗 (SBWT) 系统已经建立,但在日本的医疗保健专业人员未充分利用.
- 医疗保健提供者对SBWT的认识较低,需要有针对性的教育干预措施.
研究的目的:
- 评估SBWT教育计划对日本北海道医疗保健专业人员的有效性.
- 评估教育干预后与SBWT相关的意识,兴趣和行为变化.
- 为了比较基于讲座的学习形式与自我指导的学习形式的有效性.
主要方法:
- 这是一项为期两年的基于问卷的研究,在北海道的八个医疗机构进行.
- 一个包含基于讲座和自我指导的学习模块的教育计划,涉及六个关键的SBWT组件.
- 计划前后调查以测量意识,兴趣和报告行为的变化.
主要成果:
- 计划前的SBWT意识很低 (36.7%的医生,28.2%的员工);计划后的意识显著增加 (81.3%的医生,58.3%的员工).
- 对SBWT的兴趣有所改善,医务人员的收益更大.
- 基于讲座的学习比自我指导的学习更有效地提高了意识,兴趣和参与度,特别是在医疗人员中.
结论:
- 该教育计划有效地提高了医疗保健专业人员对SBWT的认识和兴趣,特别是通过基于讲座的交付.
- 定制的教育策略至关重要,考虑到不同的基线知识水平.
- 未来的努力应侧重于计划的可持续性,国家扩张,并评估对患者护理和结果的长期影响.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
251
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
251
Inflammatory Bowel Disease IV: Pharmacological Management
80
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
80
Irritable Bowel Syndrome III: Medical and Nursing Management
123
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
123
Inflammatory Bowel Disease V: Surgical Management
67
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
67
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
106
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
106
Drugs for Treatment of Ulcerative Colitis in IBD
107
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
107


